novo nordisk glp 1 products GLP-1 generics in the US are losing ground without disappearing Administration Anounces Landmark GLP-1 Pricing

We can't wait to welcome our speaker faculty: Raveena Asquith-Bhondi, PhD Adriana Ramos Alok Pachori Belle van Rosmalen Kristin Fiorino Maria Trujillo Rosemarie Sellati Fady Botros Allison Goldfine Cecilie Heerdegen Jepsen

There are currently two major players with a decisive head start in the obesity drug space: Eli Lilly (LLY) and Novo Nordisk (NVO)

Learn how GLP-1 drugs like Ozempic can affect your teeth and gums, from dry mouth to gum disease risks

Each template is built on a framework tested and refined through extensive industry experience

But their side effects often drive people to stop using them over the long term.